Gapping down
In reaction to disappointing earnings/guidance:
- HNI -19.8%, INVE -15%, WHR -9.7%, LOGI -6.3%, MAS -4.5%, WDR -3.9%, BIIB -2.9%, NVS -2.2%, R -2.2%, CNC -2%, JBLU -1.9%, PHM -1.4%, ZION -1.2%, LMT -1.1%, RMBS -0.7%, EDU -0.5%, RF -0.5%, SAH -0.5%
Other news:
- IMDZ -13.5% (commences 16 mln common stock offering)
- CRBP -7.4% (commences common stock offering)
- QURE -2% (commences 5 mln common stock offering)
- CWH -1.9% (files 6.7 mln share Class A common stock offering by selling stockholders; also provided YTD estimates -- 9-mo revs of $3.38-3.4 bln, income from ops of $314-318 mln)
- FRC -1.6% ( to sell 2 mln shares of common stock in an underwritten public offering)
- SNES -1.4% (following 70%+ surge higher)
- HTGM -1.1% (after seeing afternoon momentum - ending the day up 25%)
- AUPH -1% (Robert W. Duggan disclosed lowered active stake)
Analyst comments:
- VECO -3.4% (downgraded to Sector Weight from Overweight at KeyBanc Capital Mkts)
- RHT -2.2% (downgraded to Underperform from Neutral at BofA/Merrill)
- TERP -2.2% (resumed with a Underperform at BofA/Merrill)
- HFC -1% (downgraded to Underperform from Neutral at Macquarie)
- HBI -0.9% (downgraded to Perform from Outperform at Oppenheimer)
- GE -0.5% (downgraded to Underperform at Oppenheimer)
Gapping up
In reaction to strong earnings/guidance:
- KNL +13%, GPK +8.6%, CAT +6.7%, PII +5.7%, GM +4.2%, HMST +3.8%, CR +3.4%, CLB +3.4%, CIT +3.2%, AMTD +3%, CAJ +2.9%, LLY +2.7%, FCAU +2.5%, MMM +2.5%, SWK +1.9%, YNDX +1.6%, PCAR +1%, UTX +0.7%
M&A news:
- HES +2.9% (Hess to sell its interests in offshore Equatorial Guinea to Kosmos Energy (KOS) and Trident Energy for $650 million)
Other news:
- CBIO +10.6% (Catalyst Biosciences and Mosaic Biosciences enter collaboration agreement)
- VKTX +8.6% (presents results from an eight-week study of VK2809 )
- VICL +5.7% (pursuing early stage development of a novel treatment for chronic hepatitis B virus based on its DNA and lipid-delivery technologies), EGO +5.2% (after 25% decline on mine update)
- ALXN +5.2% (receives FDA approval for Soliris)
- TNDM +4.6% (continued strength; also Armistice Capital discloses 4.99% passive stake)
- IPXL +3.2% (received final FDA approval on its Abbreviated ANDA for a generic version of Renvela (sevelamer carbonate) tablets, 800 mg; co has immediately initiated commercialization activities)
- DEST +3.1% (continued strength)
- ZEAL +2.4% (granted orphan drug designation by the FDA for glepaglutide for the treatment of short bowel syndrome)
- INO +2.2% (announces results of a study in which a DNA vaccine provided 100% protection for non-human primates challenged with a lethal dose of the Lassa fever virus)
- DE +1.6% (in sympathy with CAT)
- ICPT +1.4% (announces positive results from phase 2 AESOP trial evaluating OCA for treatment of patients with primary sclerosing cholangitis - met the primary endpoint)
- CNHI +1.3% (in sympathy with CAT)
- SPPI +1.2% (initiated with a Buy at Guggenheim)
Analyst comments:
- CRIS +8.9% (initiated with a Buy at Guggenheim; tgt $7)
- SCYX +8.2% (initiated with a Buy at Guggenheim; tgt $6)
- PRTY +2.7% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- CTMX +2.5% (initiated with a Overweight at Cantor Fitzgerald)
- HAS +1.6% (upgraded to Overweight from Equal Weight at Barclays)
- DK +1.3% (upgraded to Outperform from Neutral at Macquarie)
- PQG +0.8% (initiated with a Buy at Nomura, among others)
- CELG +0.7% (initiated with a Buy at Guggenheim)
UK
LUX IM -1% WEAK Q3 SALES IN-LINE WITH LOW CONS. EXPECTATIONS; RETAIL LFL -5.1% v CONS -3.5% WILL BE TAKEN NEGATIVELY.
Macquarie
* Bunzl BNZL- Inline, more acquisitions planned. Unch
NOVN called +1%.. - pretty decent quality, should be up rel today
After Hours Summary: KNL +12% higher and HNI -16%, INVE -15%, WHR -6.5% lower following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: KNL +12.3%, HMST +3.8% (light volume), CLB +2.6% (light volume)
Companies trading higher in after hours in reaction to news: IPXL +5.1% (received final FDA approval on its Abbreviated ANDA for a generic version of Renvela [sevelamer carbonate] tablets, 800 mg; co has immediately initiated commercialization activities), TNDM +5% (continued strength; also Armistice Capital discloses 4.99% passive stake), SNES +4.1% (continued momentum following 80%+ surge higher), EGO +3.9% (modestly rebounding after 25% decline today), DEST +3.1% (continued strength), ICPT +2.1% (announces positive results from phase 2 AESOP trial evaluating OCA for treatment of patients with primary sclerosing cholangitis - met the primary endpoint), GLW +1.7% (ahead of earnings), AMGN +0.7% (announces top-line results of the Phase 3 A.R.R.O.W. trial met primary endpoint), HBI +0.6% (light volume; initiated after the close with Buy and $29 tgt at Deutsche Bank)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: HNI -16.1%, INVE -15%, WHR -6.5%, RMBS -0.7%
Companies trading lower in after hours in reaction to news: IMDZ -15.4% (commences 16 mln common stock offering), CRBP -4.7% (commences common stock offering), QURE -4.2% (commences 5 mln common stock offering), CWH -3.1% (files 6.7 mln share Class A common stock offering by selling stockholders; also provided YTD estimates), AUPH -3% (Robert Duggan disclosed lowered active stake), FRC -2.1% (to sell 2 mln shares of common stock in an underwritten public offering), ALXN -1% (continued weakness), HFC -0.5% (downgraded at Macquarie after the close), GE -0.4% (downgraded after the close to Underperform from Perform at Oppenheimer)
Closing Market Summary: Winning Streak Comes to an EndStocks moved lower on Monday, ending a week-long stretch of record finishes. The major indices kept near their flat lines throughout the morning, but tumbled to new lows in the afternoon. The S&P 500 lost 0.4%, while the Nasdaq and the Russell 2000 underperformed, losing 0.6% and 0.8%, respectively. The Dow finished ahead of its peers, but still lost 0.2%.
Earnings season took somewhat of a breather on Monday, but will pick back up Tuesday morning with releases from McDonald's (MCD 163.34, -2.96), 3M (MMM 221.55, +0.23), Caterpillar (CAT 131.68, +0.32), and United Technologies (UTX 120.89, -0.04)--in addition to many other heavyweights.
Still, there were several notable post-earnings movers on Monday, including V.F. Corp (VFC 69.95, +3.57), Seagate Tech (STX 39.35, +4.41), and Hasbro (HAS 89.75, -8.44).
V.F. Corp--which owns apparel brands like Wrangler and The North Face--and disk-drive maker Seagate Tech soared 5.4% and 12.6%, respectively, after reporting better-than-expected earnings and revenues. Conversely, toymaker Hasbro plunged 8.6% after issuing disappointing sales guidance for the holiday season, which overshadowed the company's above-consensus earnings.
Outside of earnings, industrial giant General Electric (GE 22.32, -1.51) dropped 6.3% after both Morgan Stanley and UBS downgraded GE shares on the heels of Friday's underwhelming earnings report. The S&P 500's industrial sector declined by 0.8%, settling alongside the consumer discretionary (-0.7%) and telecom services (-1.0%) groups at the bottom of the sector standings.
Within the consumer discretionary space, Under Armour (UAA 16.85, -0.63) exhibited particular weakness, losing 3.6%, after the Wall Street Journal reported that co-founder Kip Fulks is taking a sabbatical and that the sportswear manufacturer is considering exiting small sports categories such as tennis and fishing.
On a positive note, the heavily-weighted financial sector (-0.1%) held up relatively well, finishing near the top of the day's leaderboard. The countercyclical consumer staples (-0.1%) and utilities (+0.1%) sectors also put together a relatively positive showing. Following Monday's slim victory, the utilities space leads all other groups for the month of October with a month-to-date gain of 3.5%.
Elsewhere, European equities ticked higher on Monday, evidenced by the Euro Stoxx 50 index, which added 0.1%. However, Spain's IBEX (-0.8%) underperformed after Prime Minster Mariano Rajoy invoked Article 155 of Spain's constitution, which allows the central government to take control of the Catalonia region following its vote in favor of independence.
In Asia, Japan's Nikkei rose 1.1% on Monday, marking its 15th consecutive advance--and longest-ever winning streak--after the LDP/Komeito coalition kept its super majority following a national election over the weekend. As a result, Prime Minister Shinzo Abe will likely serve another three-year term.
There wasn't much movement in the U.S. Treasury market on Monday, with the benchmark 10-yr yield finishing unchanged at 2.38%. Shorter-dated issues showed relative weakness, sending the 2-yr yield one basis point higher to 1.58%. Meanwhile, the U.S. Dollar Index jumped 0.2% to 93.75.
Investors did not receive any economic data on Monday, and Tuesday's economic calendar is also blank.
- Nasdaq Composite +22.4% YTD
- Dow Jones Industrial Average +17.8% YTD
- S&P 500 +14.6% YTD
- Russell 2000 +10.3% YTD
![]()